Author:
Tassinari Davide,Maltoni Marco,Sartori Sergio,Fantini Manuela,Poggi Barbara,Ravaioli Alberto
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. ASCO (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14:671?679
2. Belda-Iniesta C, DeCastro Carpeno J, Fresno Vara JA, et al (2003) Eicosapentanoic acid as a targeted therapy for cancer cachexia. J Clin Oncol 21:4657?4658
3. Beller E, Tattersall M, Lumley T, et al (1997) Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group. Ann Oncol 8:277?283
4. Bruera E, Ernst S, Hagen N, et al (1998) Effectiveness of megestrol acetate in patients with advanced cancer: a randomized double blind, crossover study. Cancer Prev Control 2:74?78
5. Bruera E, Neumann CM, Pituskin E, et al (1999) Thalidomide in patients with cachexia due to terminal cancer: preliminary report. Ann Oncol 10:857?859
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献